QuBind

Curated by Signal

AI-driven T-cell immunotherapy for advanced personalized healthcare

Overview

AI-driven T-cell immunotherapy for advanced personalized healthcare. The company harnesses next-generation sequencing technologies to unlock intricate details of the immune system response to revolutionize patient treatment and advancing the field of personalized medicine.

Key facts

Founded: 2022
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Calibra Medical
Provider of insulin patches and delivery devices
Life Sciences TechnologyRedwood City, United States
LuminaCare Solutions
Analytics for Bacterial Infections
Life Sciences TechnologyBoston, United States
PCOS Support Center
Online store offering nutritional supplemnets for women health
Life Sciences TechnologyCape Coral, United States

About QuBind

What does QuBind do?

AI-driven T-cell immunotherapy for advanced personalized healthcare.

Where is QuBind headquartered?

QuBind is headquartered in Boston, United States.

When was QuBind founded?

QuBind was founded in 2022.

Which sector is QuBind in?

QuBind operates in Life Sciences Technology.

Who are QuBind's competitors?

Companies similar to QuBind include Calibra Medical, LuminaCare Solutions, and PCOS Support Center.